相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation
Deli Zhang et al.
NATURE COMMUNICATIONS (2019)
Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017
Thomas R. Einarson et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Data Linking Diabetes Mellitus and Atrial Fibrillationd-How Strong Is the Evidence? From Epidemiology and Pathophysiology to Therapeutic Implications
Razvan C. Serban et al.
CANADIAN JOURNAL OF CARDIOLOGY (2018)
The role of immune cells in atrial fibrillation
Yaozhong Liu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic Implications
Gong Chen et al.
FRONTIERS IN PHYSIOLOGY (2018)
PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1 alpha axis
Maayan Waldman et al.
EXPERIMENTAL CELL RESEARCH (2018)
PARP1 orchestrates epigenetic events setting up chromatin domains
Fabio Ciccarone et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Left Atrial Reverse Remodeling Mechanisms, Evaluation, and Clinical Significance
Liza Thomas et al.
JACC-CARDIOVASCULAR IMAGING (2017)
Polydatin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation by inhibiting NF-κB/NLRP3 inflammasome activation via the AMPK/SIRT1 pathway
Lvyi Chen et al.
FOOD & FUNCTION (2017)
Heart Disease and Stroke Statistics-2016 Update A Report From the American Heart Association
Dariush Mozaffarian et al.
CIRCULATION (2016)
Cross-talk between macrophages and atrial myocytes in atrial fibrillation
Zewei Sun et al.
BASIC RESEARCH IN CARDIOLOGY (2016)
Acute blood glucose fluctuation enhances rat aorta endothelial cell apoptosis, oxidative stress and pro-inflammatory cytokine expression in vivo
Na Wu et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Assessment of Mitochondrial Dysfunction and Monoamine Oxidase Contribution to Oxidative Stress in Human Diabetic Hearts
O. M. Duicu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies
Christos A. Goudis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function
Felix Y. Feng et al.
MOLECULAR CELL (2015)
Inflammation and the pathogenesis of atrial fibrillation
Yu-Feng Hu et al.
NATURE REVIEWS CARDIOLOGY (2015)
Probucol Prevents Atrial Remodeling by Inhibiting Oxidative Stress and TNF-α/NF-κB/TGF-β Signal Transduction Pathway in Alloxan-Induced Diabetic Rabbits
Huaying Fu et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2015)
Theobromine increases NAD+/Sirt-1 activity and protects the kidney under diabetic conditions
Alexandros Papadimitriou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Advanced glycation end-products impair Na+/K+-ATPase activity in diabetic cardiomyopathy: Role of the adenosine monophosphate-activated protein kinase/sirtuin 1 pathway
Qiong Yuan et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2014)
Atrial Remodeling and Atrial Fibrillation
Stanley Nattel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Automodification switches PARP-1 function from chromatin architectural protein to histone chaperone
Uma M. Muthurajan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The effect of the Ras homolog gene family (Rho), member A/Rho associated coiled-coil forming protein kinase pathway in atrial fibrosis of type 2 diabetes in rats
Jinling Chen et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1 alpha axis in db/db mice
M. Y. Kim et al.
DIABETOLOGIA (2013)
Beyond DNA repairs additional functions of PARP-1 in cancer
Alice N. Weaver et al.
FRONTIERS IN ONCOLOGY (2013)
Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study
Rachel R. Huxley et al.
HEART (2012)
Sirt-1 Is Required for the Inhibition of Apoptosis and Inflammatory Responses in Human Tenocytes
Franziska Busch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Atrial Substrate Properties and Outcome of Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation Associated With Diabetes Mellitus or Impaired Fasting Glucose
Tze-Fan Chao et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Substrate-Specific Derangements in Mitochondrial Metabolism and Redox Balance in the Atrium of the Type 2 Diabetic Human Heart
Ethan J. Anderson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
A Nuclear Poly(ADP-Ribose)-Dependent Signalosome Confers DNA Damage-Induced IκB Kinase Activation
Michael Stilmann et al.
MOLECULAR CELL (2009)
Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE trial)
Tonje Amb Aksnes et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
PARP mediates structural alterations in diabetic cardiomyopathy
Jane Chiu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2α deacetylase activity
JB Pillai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Substrate size as a determinant of fibrillatory activity maintenance in a mathematical model of canine atrium
RQ Zou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes
P Pacher et al.
DIABETES (2002)
分享论文
